Appointed by Governor: Esther H. Chang, Ph.D.; Stephen V. Desiderio, M.D., Ph.D.; Nariman Farvardin, Ph.D.; Patrick Y. Lu, Ph.D.; Lisbeth Pettengill; Peter Searson, Ph.D.; Peter W. Swaan, Ph.D.; Lawrence Tamarkin, Ph.D.
Appointed by Senate President: Jennie M. Forehand
Appointed by House Speaker: Susan C. Lee
Ex officio: Judith A. Britz, Ph.D., designee of Secretary of Business & Economic Development; Robert A. Rosenbaum, Designee of Chair, Maryland Technology Development Corporation; Renee M. Winsky, designee of Chair, Tech Council of Maryland.
Ex officio (federal): Margaret A. Hamburg, M.D., Commissioner, U.S. Food & Drug Administration; Francis S. Collins, M.D., Ph.D., Director, National Institutes of Health; Patrick D. Gallagher, Ph.D., Director, National Institute of Standards & Technology; David Kappos, J.D., Director, U.S. Patent & Trademark Office & Under Secretary of Commerce for Intellectual Property.
Staff: Benjamin H. Wu, Esq.
c/o Maryland Biotechnolgy Center
World Trade Center Baltimore, Suite 700
401 East Pratt St., Baltimore, MD 21202
(410) 767-3619; fax: (410) 767-6608
On June 1, 2010, the Task Force to Study Nanobiotechnology was authorized (Chapter 163, Acts of 2010).
Nanobiotechnology is a rapidly developing field of study researching biosystems at the nano level, where one nanometer equals one-billionth of a meter. The Task Force studied how Maryland benefits from nanobiotechnology and what the State currently is doing to support the growth of this field of study. The Task Force made recommendations on what Maryland should do to promote the growth of nanobiotechnology in the State.
On January 1, 2011, the Task Force submitted its report to the Governor and General Assembly. Authorization for the Task Force ended May 31, 2011.
|| Search the Archives || Education & Outreach || Archives of Maryland Online ] Governor General Assembly Judiciary Maryland.Gov